Friday, February 21, 2020 9:48:52 AM
ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinski on Q4 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4326092-rewalk-robotics-ltd-rwlk-ceo-larry-jasinski-on-q4-2019-results-earnings-call-transcript?page=5
ReWalk personnel 6.0 increased average selling price from an average of $77,000 to $87,000
Question-and-Answer Session page 5
-So to start off what's the total number of eligible lives or eligible patients under the insurers in Germany that you expect to come on board in 2020?
-Well, it vary by groups and timing. Specifically there are roughly 80,000 injured spinal cord people in Germany and the majority of those -- vast majority of those would have rights for coverage. Of those 80,000 by the time you look at all inclusion exclusion criteria and everything qualification that number comes down to about 8,000 or about 10% of the pool. So that's the available pool and the majority of that pool if it's a work-related injury probably almost all of them are covered. If it's a private injury, the majority would be covered. Is that more specific enough to cover your answer?
So if we assume that 10% of the 8K patients in Germany are eligible for a 6.0 Rewalk suit, there are 800 then I come to a possible turnover for Germany alone 800 x $ 87,000 = 69million dollars and that is only for Germany !!
--->>And this does not include revenue growth from other countries
all imo
-Buy, Sell and trade stocks at your own risk.
-What I say in my posts are strictly my opinions.
-So do your own DD (Due Diligence) and take your own decisions.
Recent RWLK News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:16:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 12:46:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 01:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2024 11:34:09 AM
- VA STAND Act introduced in the United States Senate • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Lifeward Announces Reverse Share Split • GlobeNewswire Inc. • 03/13/2024 03:45:17 PM
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b • GlobeNewswire Inc. • 03/01/2024 01:45:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:15:25 PM
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 01:00:07 PM
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:15:24 PM
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- ReWalk Robotics Expands Direct Sales Coverage to Canada • GlobeNewswire Inc. • 01/12/2024 01:30:00 PM
- ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 • GlobeNewswire Inc. • 01/11/2024 10:00:06 PM
- First ReWalk Personal Exoskeleton Claim Paid by Medicare • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:04:05 PM
- ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting • GlobeNewswire Inc. • 11/30/2023 09:45:00 PM
- ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:37:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2023 11:39:22 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM